Background: Failure of maturation occurs in 30%-60% of arteriovenous fistula (AVF) creation for hemodialysis, with highest rates in distal radiocephalic fistulas. This is partly due to initial small blood vessel size with limited blood flow capacity. Forearm exercise has shown potential as stimulus for increasing blood vessel size in patients with end-stage renal disease (ESRD) and may promote maturation of AVFs in the upper limb when applied postoperatively. However, it is unknown if forearm exercise increases blood vessel size pre-operatively, which may contribute to more distal AVF creation and raise success rates of AVF surgery. This study will investigate these issues.
Introduction

Arteriovenous fistula maturation
Since 2013, the incidence of Europeans with end-stage renal disease (ESRD) requiring dialysis is 135 per million persons (pmp). Specifically, in the Netherlands (incidence 115 pmp) this translates to almost 2000 people depending on renal replacement therapy per year, of which 1400 require a new hemodialysis access per year (1, 2) .
Arteriovenous fistulas (AVFs) are the preferred method of vascular access for maintenance hemodialysis (3) . In order to function properly, the venous outflow of the AVFs need maturation to have an adequate diameter for cannulation and sufficient blood flow for hemodialysis. According to the Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines, AVF maturation is clinically considered successful if, 6 weeks after surgery the fistula supports a flow of 600 mL/min, is located not deeper than 6 mm from the skin surface and has a diameter greater than 6 mm (4).
The creation of an AVF as distally as possible decreases the chance of hemodialysis-induced distal ischemia (HAIDI) and furthermore preserves the possibility of more proximal AVF creation in the elbow. Moreover, this limits cardiac complications due to high flow AVF and subsequent high cardiac output (5). It is common practice to primarily aim for a radiocephalic fistula (RCAVF) at the wrist (6). However, rates of RCAVF primary nonmaturation are as high as 30%-60% (7, 8) . In case of AVF failure in time for dialysis initiation, a central venous catheter (CVC) is needed, with increased risk of infection and venous obstruction (9) . Additionally, the AVF itself may need surgical or endovascular revision procedures. AVFs needing one or more procedures to promote maturation experience significantly decreased survival compared to spontaneously maturing AVFs (10) . Thus, methods to improve AVF maturation rates are clearly needed.
Forearm exercises
Small diameter blood vessels and low blood flow are known reasons for non-maturation of AVFs. Forearm exercise has proven to acutely increase the diameter of the cephalic vein in dialysis patients with recently created AVFs (11) . When applied routinely by ESRD patients without AVFs, forearm exercise sustainably improves cephalic vein volume two-fold within six weeks (12) . A study among 23 stage 3-4 ESRD patients without arterial disease suggests that these beneficial changes, including increasing arterial performance, can even be achieved within 4 weeks (13) . Similar results regarding venous distention were achieved in the contralateral (non-AVF) arm of 14 long-term dialysis patients. Additionally, in this study there was a small but significant effect for daily 30-minute forearm exercise on arterial diameter (14) . Based on these small, non-randomized studies, international guidelines recommend regular forearm exercise in the first months after AVF creation (4). Our hypothesis is that when these exercises are applied pre-operatively, causing larger blood vessel size and increased blood flow, this may facilitate more distal AVF creation, and better maturation. There are no data on whether these exercises indeed result in an increased AVF maturation rate.
Supervision of the forearm exercises is critical, as it is known from other vascular surgical areas (intermittent claudication) that supervised exercise therapy is superior to all other forms of exercise therapy and that intensity of supervision is related to the magnitude of the treatment effect (15) .
Study design and treatment
This study is designed as a multicenter randomized controlled study in subjects who are scheduled for creation of an AVF for maintenance hemodialysis, based on standard care criteria. As part of regular care, a pre-operative duplex study of the arteries and veins of both arms following a strict protocol will be performed. Vein diameters, both with and without tourniquet, will be measured at mid-upper arm, elbow, midlower arm and wrist. Furthermore, an extra measurement of vein diameter at these locations will be taken after 3 minutes of forearm exercises in the non-dominant arm, without tourniquet. All patients will warm up their arms for 5 minutes before duplex ultrasound. Details on our duplex study protocol and locations of measurement can be found in Figures 1A and 1B. Immediately after Duplex arm measurements, ipsilateral brachial artery pressure will be measured using a standard automated sphygmomanometer. We aim to perform the duplex ultrasound by one blinded investigator.
After obtaining informed consent at the outpatient clinic, eligibility will be assessed. All patients aged >18 years, planned for AVF surgery and having cephalic vein diameters >1 mm, are eligible to participate. This can be either predialysis patients, or patients who are already on dialysis, either by peritoneal dialysis, via a CVC or an AVF in the contralateral arm. Patients who are unable to attend the exercises or who are unlikely to adequately comply with the trial's procedures are excluded. Furthermore, patients who are enrolled in another clinical trial on fistula maturation (16) or had an AVF before on the ipsilateral arm are excluded. Based on the duplex results, an initial operative plan will be made and the patient will be scheduled for surgery. Patients having a radial artery diameter >1.6 mm and a cephalic vein diameter >1.9 mm without tourniquet are eligible for RCAVF.
Following inclusion, 6-8 weeks prior to surgery, patients will receive the forearm training gear: hand grip trainers coupled to an application, using an e-device. Next, they will receive instruction and training schedule containing exercises for 30 minutes per day, in 3 sessions of 10 minutes, and 20 squeezes per minute, for 6 weeks. Patients will be referred to a physiotherapist for once-weekly group sessions where training will be monitored and intensified. Moreover, grip force will be objectified using a dynamometer and forearm circumference (5 cm distal from the elbow crease) will be measured. Questionnaires on kidney disease quality of life-short form (KDQOL-SF) and burden of the exercises will also be performed.
After 6 weeks, the duplex investigation is repeated and diameter of cephalic vein at pre-specified locations, diameter of radial artery and blood pressure at both sides are measured. Then the patient is contacted by telephone by the vascular surgeon who can finalize the operative plan.
The operation is conducted at 6-8 weeks following initiation of forearm training. Follow-up visits are routinely planned at 6 weeks postoperatively accompanied by a duplex investigation. At 12 weeks, a follow-up telephone consultation by one of the vascular surgeons is planned to ask is the AVF is already used for hemodialysis, and to check for non-surgical patency-promoting interventions, such as balloon angioplasty (Tab. I, schedule of visits).
Endpoints
The primary endpoint is per-patient increase in cephalic vein or radial artery diameter after six weeks of forearm exercise, as assessed by duplex ultrasound at pre-specified locations in the forearm. Secondary endpoints will be cephalic vein diameter and flow six weeks after surgery. Furthermore per-patient change of cephalic or basilic vein diameter from surgery until 6 weeks postoperatively, and finally per-patient change in vascular diameter after tourniquet measurements, and AVF flow 6 weeks postoperatively. We will also register if there is a change in operative plan after 6 weeks of performing exercises
Statistics
Sample size calculation
Recent evidence suggests that an RCAVF flow rate of <200 mL/min one week after AVF surgery is predictive of AVF failure (16) . In this study, AVFs 'at risk' of being patent but with limited blood flow at one week, equaled a flow of 120 mL/min. In order to achieve 200 mL/min in these patients the flow must be raised to 66%. The flow rate (Q) is constituted of the area (A) and the velocity (v) in the formula Q = Av. Translating this to diameter results in the formula Q (mL/min) = π d 2 /4 (cm 2 ) × v. Since time-adjusted velocity in the cephalic vein seems independent of AVF presence (16), the increase in flow mainly results from an increase in venous volume. As normal cephalic vein diameter is around 2 mm (17), an increase of 0.58 mm would mean a 1.66 increase in area, and assuming a stable velocity as observed before (17) , also a 1.66 increase in flow rate. The within-patient standard deviation (SD) of duplex ultrasound measurements in a study among 23 patients with maturing AVF equaled a maximum of 0.6 mm (11).
To detect a 0.58 mm improvement in mean venous diameter in the treatment group with a power of 80% and an alpha level of 5%, 16 subjects per group need to be enrolled in the study. Allowing for a 25% drop-out, 20 subjects will be enrolled per group, with a total of 40 patients.
Primary study parameters
The change in continuous variables in the primary endpoint will be compared within patients between upper extremities (arms) of patients from either treatment groups for statistically significant differences using a one-way repeated measures ANOVA over time model.
In case of non-normality of an endpoint, a non-parametric analysis will be used or the variable will be logarithmically transformed.
Secondary study parameters
To investigate whether supervised, monitored forearm exercise leads to a change in surgical AVF site, the rate of peri-operative changes in AVF location is monitored. Differences will be tested for statistical significance using a Chi-Square test.
Maturation rates are compared between groups using a mixed between-within ANOVA model. To investigate whether response to supervised, monitored forearm exercise predicts AVF maturation an ANCOVA model will be designed.
Time line
The protocol was approved by the ethical committee in November 2016. The first patient is expected to be enrolled in the trial in October 2017, when the development of the handgrip trainers coupled to an e-device application is finalized. Currently, two centers have agreed to participate in the PINCH trial. Taking into account the number of patients requiring an AVF each year in the participating hospitals, we expect that the trial will be ongoing for approximately two years.
Discussion
Choice of endpoints
Since this is the first randomized trial investigating the influence of performing preoperative forearm exercises in predialysis patients, we chose to use per-patient change in cephalic vein or radial artery diameter after six weeks as the primary outcome, and not (yet) maturation or non-maturation.
If our hypothesis is correct -that pre-operative forearm exercises lead to a larger vein and/or artery diameter, this may lead to a greater number of RCAVFs being created, instead of brachiocephalic AVFs (BCAVFs). When pre-operative forearm exercises indeed show a significant increase in vein diameter, a larger confirmatory trial with maturation or nonmaturation as an endpoint will be performed subsequently.
Forearm exercises
In this study we chose to have patients perform the preoperative forearm exercises for 6 weeks, 30 minutes per day, and a frequency of 20 squeezes per minute. Since this is the first randomized trial on this topic and few studies are available on this matter, it is not known what the best exercise regimen would be in means of duration, frequency and interval of squeezing. This regimen is based on the information that is available from studies on postoperative forearm exercises (9) (10) (11) (12) .
We chose to use a handgrip trainer linked to an e-device for several reasons. First, this enables us to monitor treatment adherence and efficacy remotely in real-time, thereby facilitating additional interventions to stimulate exercising. Moreover, the e-device will remind the patient when it is time to exercise on days that exercises might be forgotten and it may prompt patients to complete e-questionnaires on quality of life and treatment burden on specific time points.
Conclusions
Maturation in AVF creation remains a challenge for vascular surgeons and nephrologists. With the knowledge of the influence of venous and arterial diameter on maturation and the promising results of post-operative forearm exercises in the past, we initiated this trial on preoperative forearm exercises.
The PINCH trial is the first randomized study investigating the influence of preoperative, supervised forearm exercises in (pre-) dialysis patients. This study will start in fall of 2017 and is planned to enroll the last patient in 2019.
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